Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-22
1995-08-08
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514345, 546192, 546255, 546217, 546261, C07D21170, A61K 3144
Patent
active
054399203
ABSTRACT:
The invention relates to a compound of formula: ##STR1## and its addition salts with pharmaceutically acceptable acids. These compounds are useful in therapy as sedatives. Figure none
REFERENCES:
patent: 4414219 (1983-11-01), Martin
patent: 4663328 (1987-05-01), Lafon
Also Balsamo et al., "An approach to the knowledge of the steric requirements for alpha -adrenoreceptor direct activation alpha -Adrenergic properties of new 3-piperidinols", European Journal of Medicinal Chemistry.Chimica Therapeutica, vol. 16, No. 2, 1981, pp. 163-169, 1981.
Zlata Raza et al., "Preparation and properties of some prochiral and chiral precursors of S-3-(3-hydroxyphenyl)-1-propylpiperidine (S-3-PPP ). . . ", Croatica Chemica Acta, vol. 64, No. 1, pp. 65-77, 1991.
Chang Ceila
Laboratoire L. Lafon
M. Mach D. Margaret
LandOfFree
1,2,5,6-tetrahydropyridine derivative, process for preparing it does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,5,6-tetrahydropyridine derivative, process for preparing it , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,5,6-tetrahydropyridine derivative, process for preparing it will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-971418